热门资讯> 正文

Neurogene定价1.25亿美元股权发行

2026-07-01 19:19

Neurogene Inc.(NGNE) 0

Neurogene (NGNE) priced a public offering of 3.5M common shares at $30.00 per share and 666,666 pre-funded warrants in lieu of common stock for certain investors.
The pre-funded warrants are exercisable immediately at a price of $0.000001 per share. The offering is expected to raise about $125M in gross proceeds before expenses and is scheduled to close on July 2, 2026, subject to customary closing conditions.
The company also granted the underwriters a 30-day option to purchase up to an additional 624,999 shares to cover overallotments.

More on Neurogene

Neurogene Inc. (NGNE) Discusses Updated Phase 1/2 Data for NGN-401 Gene Therapy in Rett Syndrome - Slideshow
Neurogene Inc. (NGNE) Discusses Updated Phase 1/2 Data for NGN-401 Gene Therapy in Rett Syndrome Transcript
Neurogene launches public stock offering
Seeking Alpha’s Quant Rating on Neurogene
Historical earnings data for Neurogene

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。